title: [Levitra in the treatment of patients with chronic prostatitis associated with sexual dysfunction].
abstract: Sixty patients with chronic prostatitis and sexual dysfunction were divided into two groups. All the patients received one-month standard course of physiotherapy. In addition, group I (n = 30) was given levitra (vardenafil; 5 mg per os each other day), the control group was not given this drug. Follow-up covered 6 months to 1.5 years. General urological examination, questionnaire survey, ultrasound investigation of male genital organs were made before, 1 and 6 months after treatment. The results were processed statistically. Levitra improves circulation in male sexual organs promoting increased arterial inflow to the prostate and penis. Aftertreatment effect persisted for half a year. Regular levitra intake (2-3 times a week) is recommended to correct circulation in the sexual system, including prostatic gland, but not only for correction of erectile dysfunction as a result of psychogenic and vascular disorders in the penis accompanying chronic prostatitis.
authors.forename: Iu M
authors.initials: IuM
authors.lastname: Esilevskiĭ
authors.forename: Iu G
authors.initials: IuG
authors.lastname: Aliaev
authors.forename: G E
authors.initials: GE
authors.lastname: Krupinov
authors.forename: T D
authors.initials: TD
authors.lastname: Zhuchenko
authors.forename: N D
authors.initials: ND
authors.lastname: Akhvlediani
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D005837:Genitalia, Male / Q000098:blood supply / Q000187:drug effects / Q000648:ultrastructure; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D026741:Physical Therapy Modalities; D010879:Piperazines / Q000627:therapeutic use*; D011472:Prostatitis / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D013450:Sulfones / Q000627:therapeutic use; D016896:Treatment Outcome; D014227:Triazines / Q000627:therapeutic use; D018608:Ultrasonography, Doppler; D000069058:Vardenafil Dihydrochloride
chemical_list: D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D013450:Sulfones; D014227:Triazines; D000069058:Vardenafil Dihydrochloride